AxoGen, Inc.
AXGN
$17.04
-$0.65-3.67%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 187.34M | 180.86M | 173.48M | 163.73M | 159.01M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 187.34M | 180.86M | 173.48M | 163.73M | 159.01M |
Cost of Revenue | 45.36M | 44.43M | 41.79M | 37.73M | 37.14M |
Gross Profit | 141.98M | 136.42M | 131.69M | 126.00M | 121.87M |
SG&A Expenses | 117.50M | 116.68M | 115.96M | 116.26M | 115.99M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 190.63M | 189.35M | 185.69M | 182.41M | 180.47M |
Operating Income | -3.29M | -8.50M | -12.21M | -18.68M | -21.46M |
Income Before Tax | -9.96M | -14.31M | -16.54M | -21.28M | -21.72M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -9.96 | -14.31 | -16.54 | -21.28 | -21.72 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -9.96M | -14.31M | -16.54M | -21.28M | -21.72M |
EBIT | -3.29M | -8.50M | -12.21M | -18.68M | -21.46M |
EBITDA | 3.45M | -1.85M | -6.05M | -13.39M | -16.97M |
EPS Basic | -0.23 | -0.33 | -0.38 | -0.49 | -0.51 |
Normalized Basic EPS | -0.14 | -0.21 | -0.24 | -0.31 | -0.32 |
EPS Diluted | -0.23 | -0.33 | -0.39 | -0.50 | -0.52 |
Normalized Diluted EPS | -0.14 | -0.21 | -0.24 | -0.31 | -0.32 |
Average Basic Shares Outstanding | 175.71M | 173.88M | 173.02M | 172.17M | 171.51M |
Average Diluted Shares Outstanding | 178.89M | 173.88M | 173.02M | 172.17M | 171.51M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |